The Steering committee is an independent group of HIV, viral hepatitis and sexually transmitted infections experts and is instrumental in helping achieve the aims and objectives of EuroTEST (formerly HIV in Europe).

The Co-Chairs

Billedresultat for daniel simoes gat Daniel Simões
Psychologist, GAT, Portugal
Daniel Simões is a Psychologist working in the third sector since 2004. He has been working in GAT (Portugal) since 2011 in both project management and policy/advocacy activities and is co-coordinating the Community Based Testing Network in Portugal. He is an EATG member, and part of the Policy Working Group Steering Committee. Daniel is currently a research fellow in the Global Public Health PhD program, in the Institute of Public Health of the University of Porto, in Portugal. 
Jürgen Rockstroh

MD, Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn, Germany

An active member of the HIV/AIDS treatment community, Dr Rockstroh was the Chairman of the German Clinical AIDS Working Group (KAAD) from 1998 to 2007. From 2007 to 2011, he was elected as the president of the German AIDS Society. He is currently President of the European AIDS Clinical Society (EACS) Governing Board. 



   Jordi Casabona 
 Scientific Director, Center for   HIV/STI Epidemiological Studies   of Catalonia (CEEISCAT)

Jordi Casabona is a medical epidemiologist working on the HIV/STI field since 1989. He is the Scientific Director of the Center for Epidemiological Studies on HIV/STI of Catalonia (CEEISCAT) (, President of the Fundació Sida i Societat and Associated Professor of Epidemiology and Preventive Medicine at the Autonomous University of Barcelona (UAB). He has been acting as a expert consultant for a number of international agencies in Latin America, Europe and Central Asia, was  the co-chair of the XIV International AIDS Conference (Barcelona 2002), has implemented different interventions in Guatemala  and has been leading several European Union funded projects, during last years focusing in the monitoring and evaluation of community based testing. 

Lella Cosmaro
Fondazione LILA Milan, Italy (INTEGRATE WP leader)
Lella Cosmaro has been working in the HIV field since 1993 in an Italian NGO, LILA - the Italian League for Fighting AIDS - one of the leading national organizations.  Over the years, LILA has become more and more involved in European policies and networks: Lella is the Italian member of the EU HIV/AIDS, Hepatitis and Tuberculosis Civil Society Forum, which she co-chaired for the period 2012-2015.  She has been a Steering Committee member of AIDS Action Europe from 2011 thru 2016, is one of the External Advisory Board Members of the EATG, has been the civil society expert in a number of WHO missions in the European Region and is involved in some of the ECDC advisory groups. LILA has been and still is a partner of many European projects and Joint Actions and is deeply involved in Italian projects, advocacy and policy issues.
Nikos Dedes

Past Chair of the Board of Directors
European AIDS Treatment Group (EATG), Greece

Nikos Dedes is chair of the ‘European AIDS Treatment Group’ (EATG), the leading European HIV activists’ network and past member of the Management Board of the European Medicines Agency (EMA).

He is also founder and chair of ‘Positive Voice’, the Greek Association of People Living with HIV and founder and vice-chair of ‘Prometheus’, the Hellenic Liver Patient Association.

Nikos participates on the Steering Committees of NEAT id (European HIV Clinical Trials Foundation) and the “HIV Outcomes – Beyond Viral Suppression” initiatives. He is a member of the HIV Treatment Guidelines Panel of European AIDS Clinical Society (EACS) and member of the Coordinating Team of the HIV/AIDS, Hepatitis & TB Civil Society Forum, an advisory group to DG Sante of the European Commission. He is also member of National Clinical Trials Ethics Committee and member of the Board of Directors of the European Forum for Good Clinical Practice (EFGCP).

Valerie Delpech

Epidemiologist, Public Health England
United Kingdom

Valerie Delpech oversees the national surveillance of HIV based at Public Health England, London, United Kingdom. She provides expert advise on a number of national and international committees and expert groups in relation to HIV surveillance, prevention and policy development and led on the production of the European Centre for Disease Control (ECDC) evidence and guidance to increase HIV testing across Europe.
Brian Gazzard

Professor of Medicine, Imperial College
School of Medicine
HIV Research Director, Chelsea & Westminster Hospital, UK

Brian Gazzard is the founding chairman of the British HIV Association (BHIVA) and sits on the Editorial Board of the BHIVA/EACS journal HIV Medicine.
  Igor Karpov

Professor, Department of Infectious Disease
Belarus State Medical University

Jack Lambert
UCD, Ireland
Professor John (Jack) Lambert is Consultant in Infectious diseases in Dublin at the Mater Misericordiae University Hospital and Professor at UCD School of Medicine.  Professor Lambert has a 25 years experience in Infectious Diseases covering HIV, Hepatitis C, and other disease areas.  He has trained in the USA, UK, and worked for 6 years in Baltimore at the Johns Hopkins Institutes and the University of Maryland Institute of Human Virology, where he developed his skills in vaccinology, HIV, and Lyme and Co Infections.  He has consultant specialty certifications in adult and pediatric infectious diseases, general medicine and pediatrics, and in sexual health (genitourinary medicine).  He currently leads the National Isolation Unit of Ireland, managing all emerging infections, including Ireland's Ebola effort
Jeffrey V. Lazarus

Professor of International Health Systems, University of Copenhagen

Prof Lazarus is an expert on infectious disease policy and health systems. He is Vice-Chairman of the board of the EASL International Liver Foundation, co-chair of the HIV Outcomes Beyond Viral Suppression coalition and a steering committee member of the European Commission’s Joint Actions on infectious diseases.

Jens D. Lundgren 
MD, Professor of Viral Diseases,
University of Copenhagen; Director, CHIP, Copenhagen, Denmark.

Professor Lundgren established CHIP, Centre for Health & Infectious Disease Research in 1994. Since, he has been actively involved in international research in the field of infectious diseases, viral infections and HIV in particular. Further, he co-chaired the HIV in Europe initiative from its conception in 2007 until 2014.
Mojca Matičič

University Medical Centre Ljubljana

Mojca Matičič has been the Head of the Viral Hepatitis Unit at the Clinic for Infectious Diseases and Febrile Illnesses, and Head of the Outpatient STI Service at the University Medical Centre Ljubljana. She leads the multidisciplinary National Viral Hepatitis Expert Group of Slovenia and is an active member of the HIV/AIDS Committee at the Slovene Ministry of Health. She is a member of the European Association for the Study of the Liver (EASL), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and advisor at WHO HIV/STD/Viral Hepatitis sector. She is a senior clinical editor of the international medical journal Hepatology, Medicine and Policy (HMAP). 
  Liudmyla Maistat

Policy and Advocacy Manager, The Medicines Patent Pool, Geneva, Switzerland

Liudmyla possesses more than 15 years of policy and advocacy experience in HIV/AIDS, viral hepatitis and access to medicines. She used to work as Senior Program Advisor with the Alliance for Public Health (International HIV/AIDS Alliance in Ukraine) where she led policy and policy activities to support the scale-up of hepatitis C diagnostics and treatment in Ukraine, EECA and other countries where Alliance operates. Liudmyla is a member of the World Health Organization (WHO) Strategy and Technical Advisory Group on viral hepatitis and the WHO guidelines’ development and peer-review groups as well as a member of the Lancet Commission on Accelerating the Elimination of Viral hepatitis. She used to chair the Hepatitis C Group for Unitaid’s NGO delegation, worked closely with various civil society groups and other stakeholders working to expand access to treatments,  and continues to serve as a member of organizing and scientific committees for international  conferences and meetings  on HIV, viral hepatitis and access to medicines. Liudmyla was recognized by the Economist as one of the leading voices for advocacy to increase access to affordable diagnostics and treatment of viral hepatitis. Liudmyla now works with the Medicines Patent Pool as Policy and Advocacy Manager to scale up access to affordable and quality assured HIV, viral hepatitis and TB  medicines  in low- and middle income countries. 
  Tom Platteau

HIV/STI clinic of the Institute of Tropical Medicine in Antwerp
Tom Platteau is mental health scientist and sexologist. He works at the HIV/STI clinic of the Institute of Tropical Medicine in Antwerp, Belgium. Since 2007, he coordinates projects on the development and implementation of novel HIV/STI testing using outreach and online strategies.


Anders Sönnerborg  

MD, PhD, Professor, Department of Medicine
Karolinska University Hospital, Sweden

Anders Sönnerborg is Professor of Infectious Diseases and Clinical Virology at Karolinska Institutet, Stockholm. He has been clinically and scientifically active in the field of HIV since 1983. He is director of the Swedish InfCare HIV cohort and of the Swedish Reference group for Antiviral Therapy. 
Thumb 200 47038439333820 Ann Sullivan
SSAT, Chealsea Westminister Hospital, UK
(OptTEST WP leader)
Dr Ann Sullivan trained in Australia and London, gaining an MD in HIV Immunology. She is now a Consultant at Chelsea and Westminster Hospital. Her specific interests include expanding HIV testing, MSM sexual health and utilising technology to improve patient care and experience. As Vice Chair of the BHIVA Audit and Standards Subcommittee, she led the 2014 National HIV Partner Notification audit. Dr Sullivan was elected as BHIVA Honorary Secretary in 2016 for a 2-year term.


Nino Tsereteli

Executive Director of "Tanadgoma"

Nino Tsereteli has been working in the field of HIV/AID for more than 12 years. In 2000, together with the group of young professionals, she founded a Non-Governmental Organization “Center for Information and Counseling on Reproductive Health – Tanadgoma”, aiming at prevention of HIV and STIs and promoting reproductive health issues among Georgian population. In 2007 Ms. Tsereteli was appointed as Executive Director of “Tanadgoma”.
John de Wit

Professor, University of New South Wales
Director, Centre for Social Research in Health

John de Wit (MSc, PhD) is professor and director of the Centre for Social Research in Health at the University of New South Wales, Sydney, and visiting professor in social psychology of health and sexuality at Utrecht University, The Netherlands. John has been undertaking and leading behavioral and social research regarding HIV, STI and sexual health for over 25 years, and his expertise and interest is especially with theory-informed research into the individual, social and structural factors that shape effective prevention, diagnosis and treatment. 
Brian West

Board of Directors, European AIDS Treatment Group (EATG)

 Brian West is on the Board of Directors of the EATG - a voluntary organisation which has more than 175 members from 47 countries in Europe. He also serves on the Steering committee of AIDS Action Europe, a pan-European NGO. Closer to home, he is a trustee/director on the board of Waverley Care, Scotland’s largest NGO provider of services for people living with HIV.
  Yazdan Yazdanpanah,
INSERM, France
Prof Yazdan Yazdanpanah, Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology, Head of an Inserm team on decision analysis in Infectious Diseases, and Professor of Medicine at Paris Diderot University, France ; Head of Infectious Disease department at Bichat Claude Bernard Hospital.
Yazdan Yazdanpanah is currently the head of an Inserm team on decision analysis in Infectious Diseases, the Head of Infectious Disease department at Bichat Claude Bernard Hospital, and Professor of Medicine at Paris Diderot University, France. Yazdan Yazdanpanah became an MD from the Lille School of Medicine, France in 1996. He qualified from the same institution first as a hepato- gastro-enterologist in 1996 and next an infectious disease specialist in 2002. He obtained a Master of Science degree in epidemiology from the Harvard School of Public Health, Boston, US in 2000, and a Ph.D degree in public health from the Bordeaux School of Public Health in 2002. In 2006, he became Professor of Infectious Disease.  His research interests include the clinical epidemiology of HIV and viral hepatitis, and the pharmaco-economics of antimicrobial agents. He is one of the coordinators of Inserm “REACTing », a network under the umbrella of Aviesan (REsearch and ACTion targeting emerging infectious disease) the goal of which is to optimize and coordinate the existing research capacities during emerging and re-emerging infection threats.  He was recently appointed Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology. Professor Yazdanpanah has published extensively in peer-reviewed journals and makes frequent presentations at numerous national and international meetings.
Wim Zuilhof

Manager of the National HIV and STI prevention programs for MSM and ethnic minorities, STI Aids Netherlands 

Wim Zuilhof works at STI Aids Netherlands as manager of the National HIV and STI prevention programs for MSM and ethnic minorities in the Netherlands. He is involved in HIV prevention policies and strategies since 1988. Among other things he initiated and coordinated the current joint online strategy for MSM in the Netherlands, a series of online behavioral surveys among MSM and HIV testing campaings for ethnic minorities and MSM.    
He contributed to the creation of the H-TEAM, a unique collaboration between all stakeholders involved in the prevention and care of HIV in Amsterdam, including key affected communities. In this consortium he coordinates  the work package on early testing and direct treatment of MSM.  
  Yusef Azad
National AIDS Trust, UK


Public Health England (PHE)    
WHO Regional Office for Europe, Division of Health Emergencies & Communicable Diseases
European Centre for Disease Prevention and Control  (ECDC)    
Regional Support Team for Europe and Central Asia UNAIDS/ONUSIDA    
European Monitoring Centre for Drugs and Drug Addiction, EMCDDA     
Hepatitis B & C Public Policy Association